Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease

Human Brain Mapping

Volumn 34, Issue 12, 2013, Pages 3308-3319

  Braskie, Meredith N ^a   Medina, Luis D ^a,e   Rodriguez Agudelo, Yaneth ^b   Geschwind, Daniel H ^a   Macias Islas, Miguel Angel ^c   Thompson, Paul M ^a   Cummings, Jeffrey L ^a,f   Bookheimer, Susan Y ^d   Ringman, John M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LERNER RESEARCH INSTITUTE   (United States)

Author keywords

APP; Early onset; Functional magnetic resonance imaging; Hippocampus; Medial temporal lobe; Mutation; PSEN1; Volume

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ALLELE; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; EDUCATIONAL STATUS; ELECTROENCEPHALOGRAM; FAMILIAL ALZHEIMER DISEASE; FAMILIAL DISEASE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; GENE MUTATION; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; MEMORY; MIDDLE TEMPORAL GYRUS; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PARAHIPPOCAMPAL GYRUS; PARIETAL CORTEX; PRIORITY JOURNAL; RISK FACTOR; TASK PERFORMANCE; TEMPORAL CORTEX; TEMPORAL LOBE;

APP; EARLY ONSET; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; MEDIAL TEMPORAL LOBE; MUTATION; PSEN1; VOLUME;

ADULT; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BRAIN; BRAIN MAPPING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MEMORY DISORDERS; MENTAL RECALL; MIDDLE AGED; MUTATION; OXYGEN; PAIRED-ASSOCIATE LEARNING; PRESENILIN-1; YOUNG ADULT;

EID: 84878838659     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22141     Document Type: Article

References (51)

1. Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B, Blennow K (2001): Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58:373-379.
2. Bassett SS, Yousem DM, Cristinzio C, Kusevic I, Yassa MA, Caffo BS, Zeger SL (2006): Familial risk for Alzheimer's disease alters fMRI activation patterns. Brain 129:1229-1239.
3. Beckmann CF, Jenkinson M, Smith SM (2003): General multilevel linear modeling for group analysis in FMRI. Neuroimage 20:1052-1063.
4. Bertram L, Tanzi RE (2008): Thirty years of Alzheimer's disease genetics: The implications of systematic meta-analyses. Nat Rev Neurosci 9:768-778.
5. Bondi MW, Houston WS, Eyler LT, Brown GG (2005): fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 64:501-508.
6. Bookheimer S, Burggren A (2009): APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Annu Rev Clin Psychol 5:343-362.
7. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW (2000): Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 343:450-456.
8. Braak H, Braak E (1991): Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82:239-259.
9. Braskie MN, Medina LD, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer SY, Ringman JM (2012): Increased fMRI signal with age in familial Alzheimer's disease mutation carriers. Neurobiol Aging 33:424.e11-e21.
10. Brouwers N, Sleegers K, Van Broeckhoven C (2008): Molecular genetics of Alzheimer's disease: an update. Ann Med 40:562-583.
11. Chételat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA, Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group (2010): Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol 67:317-324.
12. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ (2006): An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31:968-980.
13. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, Bertram L, Mullin K, Tanzi RE, Blacker D, Albert MS, Sperling RA (2005): Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 65:404-411.
14. Dickerson BC, Sperling RA (2008): Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: Insights from functional MRI studies. Neuropsychologia 46:1624-1635.
15. Filippini N, MacIntosh BJ, Hough MG, Goodwin GM, Frisoni GB, Smith SM, Matthews PM, Beckmann CF, Mackay CE (2009): Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci USA 106:7209-7214.
16. Fleisher AS, Podraza KM, Bangen KJ, Taylor C, Sherzai A, Sidhar K, Liu TT, Dale AM, Buxton RB (2009): Cerebral perfusion and oxygenation differences in Alzheimer's disease risk. Neurobiol Aging 30:1737-1748.
17. Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques PK, Collinge J, Hardy J, Hutton M, Stevens JM, Warrington EK, Rossor MN (1997): Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 120:491-501.
18. Frisoni GB, Fox NC, Jack CR Jr, Scheltens P, Thompson PM (2010): The clinical use of structural MRI in Alzheimer disease. Nat Rev Neurol 6:67-77.
19. Hamalainen A, Pihlajamaki M, Tanila H, Hanninen T, Niskanen E, Tervo S, Karjalainen PA, Vanninen RL, Soininen H (2007): Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging 28:1889-1903.
20. Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW (2007): Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiol Aging 28:238-247.
21. Heun R, Freymann K, Erb M, Leube DT, Jessen F, Kircher TT, Grodd W (2006): Successful verbal retrieval in elderly subjects is related to concurrent hippocampal and posterior cingulate activation. Dement Geriatr Cogn Disord 22:165-172.
22. Huijbers W, Pennartz CM, Daselaar SM (2010): Dissociating the "retrieval success" regions of the braEffects of retrieval delay. Neuropsychologia 48:491-497.
23. Johnson KA, Lopera F, Jones K, Becker A, Sperling R, Hilson J, Londono J, Siegert I, Arcos M, Moreno S, Madrigal L, Ossa J, Pineda N, Ardila A, Roselli M, Albert MS, Kosik KS, Rios A (2001): Presenilin-1-associated abnormalities in regional cerebral perfusion. Neurology 56:1545-1551.
24. Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA (2006): The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci 26:6069-6076.
25. Kennedy AM, Rossor MN, Frackowiak RS (1995): Positron emission tomography in familial Alzheimer disease. Alzheimer Dis Assoc Disord 9:17-20.
26. Kircher TT, Weis S, Freymann K, Erb M, Jessen F, Grodd W, Heun R, Leube DT (2007): Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J Neurol Neurosurg Psychiatry 78:812-818.
27. Li S-C, Lindenberger U.1999. Cross-level unification: a computational exploration of the link between deterioration of neurotransmitter systems dedifferentiation of cognitive abilities in old age. Nilsson L-G, Markowitsch HJ, editors.Cognitive Neuroscience of Memory.Hogrefe & Huber Publishing, Seattle.
28. Liu X, Qin S, Rijpkema M, Luo J, Fernandez G (2010): Intermediate levels of hippocampal activity appear optimal for associative memory formation. PLoS One 5:e13147.
29. Logan JM, Sanders AL, Snyder AZ, Morris JC, Buckner RL (2002): Under-recruitment and nonselective recruitment: dissociable neural mechanisms associated with aging. Neuron 33:827-840.
30. Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K (2009): CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 302:385-393.
31. McDonald CR, McEvoy LK, Gharapetian L, Fennema-Notestine C, Hagler DJ Jr, Holland D, Koyama A, Brewer JB, Dale AM (2009): Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 73:457-465.
32. Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron JC, Chavoix C (1999): Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain 122:1519-1531.
33. Mosconi L, Sorbi S, de Leon MJ, Li Y, Nacmias B, Myoung PS, Tsui W, Ginestroni A, Bessi V, Fayyazz M, Caffarra P, Pupi A (2006): Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 47:1778-1786.
34. Murrell J, Ghetti B, Cochran E, Macias-Islas MA, Medina L, Varpetian A, Cummings JL, Mendez MF, Kawas C, Chui H, Ringman JM (2006): The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: An additional fifteen families. Neurogenetics 7:277-279.
35. Patenaude B, Smith S, Kennedy D, Jenkinson M (2007): FIRST-FMRIB's integrated registration and segmentation tool. Thirteenth Annual Meeting of the Organization for Human Brain Mapping (HBM). Organization for Human Brain Mapping annual meeting (2007) Chicago, IL, USA.
36. Petersen RC (2004): Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183-194.
37. Petrella JR, Wang L, Krishnan S, Slavin MJ, Prince SE, Tran TT, Doraiswamy PM (2007): Cortical deactivation in mild cognitive impairment: High-field-strength functional MR imaging. Radiology 245:224-235.
38. Quiroz YT, Budson AE, Celone K, Ruiz A, Newmark R, Castrillon G, Lopera F, Stern CE (2010): Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease. Ann Neurol 68:865-875.
39. Remy F, Mirrashed F, Campbell B, Richter W (2005): Verbal episodic memory impairment in Alzheimer's disease: A combined structural and functional MRI study. Neuroimage 25:253-266.
40. Ringman JM, O'Neill J, Geschwind D, Medina L, Apostolova LG, Rodriguez Y, Schaffer B, Varpetian A, Tseng B, Ortiz F, Fitten J, Cummings JL, Bartzokis G (2007): Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 130:1767-1776.
41. Ringman JM, Medina LD, Braskie M, Rodriguez-Agudelo Y, Geschwind DH, Macias-Islas MA, Cummings JL, Bookheimer S (2011a)Effects of risk genes on BOLD activation in presymptomatic carriers of familial Alzheimer's disease mutations during a novelty encoding task. Cereb Cortex 21:877-883.
42. Ringman JM, Taylor K, Teng E, Coppola G, Gylys K (2011b)Longitudinal change in CSF biomarkers in a presymptomatic carrier of an APP mutation. Neurology 76:2124-2125.
43. Scholl M, Almkvist O, Axelman K, Stefanova E, Wall A, Westman E, Langstrom B, Lannfelt L, Graff C, Nordberg A (2011): Glucose metabolism and PIB binding in carriers of a His163Tyr presenilin 1 mutation. Neurobiol Aging 32:1388-1399.
44. Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA (2010): Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 12:27-43.
45. Thal DR, Rub U, Orantes M, Braak H (2002): Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800.
46. Trivedi MA, Schmitz TW, Ries ML, Torgerson BM, Sager MA, Hermann BP, Asthana S, Johnson SC (2006): Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med 4:1.
47. Tsukiura T, Sekiguchi A, Yomogida Y, Nakagawa S, Shigemune Y, Kambara T, Akitsuki Y, Taki Y, Kawashima R (2011): Effects of aging on hippocampal and anterior temporal activations during successful retrieval of memory for face-name associations. J Cogn Neurosci 23:200-213.
48. Tulving E, Kapur S, Craik FI, Moscovitch M, Houle S (1994): Hemispheric encoding/retrieval asymmetry in episodic memory: Positron emission tomography findings. Proc Natl Acad Sci USA 91:2016-2020.
49. Verghese PB, Castellano JM, Holtzman DM (2011): Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol 10:241-252.
50. Woolrich MW, Ripley BD, Brady M, Smith SM (2001): Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage 14:1370-1386.
51. Zhang Y, Brady M, Smith S (2001): Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20:45-57.